0000914190-21-000243.txt : 20210811 0000914190-21-000243.hdr.sgml : 20210811 20210811191724 ACCESSION NUMBER: 0000914190-21-000243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210809 FILED AS OF DATE: 20210811 DATE AS OF CHANGE: 20210811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rempe Stephen J. CENTRAL INDEX KEY: 0001818614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 211165092 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-09 0001180145 Cardiovascular Systems Inc CSII 0001818614 Rempe Stephen J. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Human Resources Officer Common Stock 2021-08-09 4 A 0 3929 0 A 33693 D Common Stock 2021-08-09 4 A 0 11785 0 A 45727 D Restrictions lapse as to 3,310 shares on each of 8/13/22 and 8/13/23 and as to 3,309 shares on 8/13/24. Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2022, 2023 and 2024 versus the Company's peer group. Includes 176 shares acquired on 12/31/20 and 73 shares acquired on 6/30/21 pursuant to the Company's Employee Stock Purchase Plan. /s/ Andrew Nick as Attorney-in-Fact for Stephen J. Rempe pursuant to Power of Attorney filed herewith. 2021-08-11 EX-24 2 attachment_1.htm STEPHEN REMPE POWER OF ATTORNEY

POWER OF ATTORNEY



 The undersigned hereby constitutes and appoints Alexander

Rosenstein, Jeffrey Points, Anne Meyer, Christopher J. Melsha, Joseph Schauer,

Andrew Nick or Edward Peilen, or any one of them acting alone, the undersigned's

true and lawful attorney-in-fact and agent with full power of substitution and

resubstitution, for the undersigned and in the undersigned's name, place and

stead, in any and all capacities, to sign any or all Forms 3, 4 or 5

relating to beneficial ownership of securities of Cardiovascular Systems,

Inc. (the "Issuer"), to file the same, with all exhibits thereto and other

documents in connection therewith, with the Securities and Exchange

Commission and to deliver a copy of the same to the Issuer, granting unto

said attorney-in-fact and agent full power and authority to do and perform

each and every act and thing requisite and necessary to be done in and about

the premises, as fully to all intents and purposes as the undersigned might

or could do in person, hereby ratifying and confirming all said attorney-in-

fact and agent, or his substitute or substitutes, may lawfully do or cause

to be done by virtue thereof.  The undersigned acknowledges that the

foregoing attorney-in-fact, in serving in such capacity at the request of

the undersigned, is not assuming any of the undersigned's responsibilities

to comply with Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney shall remain in effect until such time as the

undersigned is no longer subject to the provisions of Section 16 of the

Securities Exchange Act of 1934 with respect to securities of the Issuer.



 The undersigned hereby indemnifies the attorneys-in-fact for all

losses and costs the attorneys-in-fact may incur in connection with or

arising from the attorneys-in-fact's execution of their authorities granted

hereunder.



 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney

to be executed as of this 2nd day of August, 2021.



     /s/ Stephen J. Rempe